1. Home
  2. TG vs OABI Comparison

TG vs OABI Comparison

Compare TG & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$8.70

Market Cap

274.2M

Sector

Industrials

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.96

Market Cap

277.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
OABI
Founded
1988
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
274.2M
277.8M
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
TG
OABI
Price
$8.70
$1.96
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
164.8K
320.4K
Earning Date
03-11-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$691,173,000.00
$21,094,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$66.20
P/E Ratio
$133.18
N/A
Revenue Growth
43.30
3.36
52 Week Low
$6.25
$1.22
52 Week High
$9.43
$4.02

Technical Indicators

Market Signals
Indicator
TG
OABI
Relative Strength Index (RSI) 67.70 52.79
Support Level $8.38 $1.85
Resistance Level $8.98 $2.10
Average True Range (ATR) 0.34 0.08
MACD 0.12 0.00
Stochastic Oscillator 82.02 44.23

Price Performance

Historical Comparison
TG
OABI

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: